Fulekang Pharmaceutical

Zhejiang Fulekang Pharmaceutical is a Chinese pharmaceutical company specializing in the development, manufacturing, and commercialization of finished dosage forms and active pharmaceutical ingredients (APIs). Founded in 2002 and headquartered in Quzhou, Zhejiang, the company focuses on chronic disease management, particularly in the therapeutic areas of endocrinology, cardiovascular health, and gastroenterology. Its product portfolio is anchored by sustained-release formulations of essential medicines, such as metformin and gliclazide, designed to improve patient compliance in diabetes care. Fulekang operates a dedicated R&D center in Shanghai that focuses on drug delivery systems and the development of improved new drugs (Class 2). The company's manufacturing facilities are GMP-certified, supporting its role as a significant supplier in the domestic Chinese market. Fulekang is recognized as a National High-tech Enterprise and continues to expand its pipeline through consistency evaluation and innovative formulation research.